Super PiggyBac Transposase Expression Vector

Catalyze your PiggyBac genome engineering with this enhanced, hyperactive transposase that can insert any-length DNA segment into the genome

Catalog Number
Add to Cart

Super piggyBac Transposase expression vector (replaces PB200A-1)

10 µg
$ 412
Contact Us Speak to a specialist


Get easy, consistent transgenesis

At the heart of SBI’s PiggyBac Transposon System* is the Super PiggyBac Transposase, an engineered, hyperactive version of the enzyme that can efficiently integrate any-sized DNA insert into the genome.

Why use the PiggyBac Transposon System?

Easy, consistent transgenesis with no limits on cargo size—For transgenesis that’s easy, consistent, and not limited by cargo size, SBI’s PiggyBac Transposon System is an excellent choice. The system consists of a PiggyBac Vector and the Super PiggyBac Transposase which recognizes transposon-specific inverted terminal repeats (ITRs) and efficiently integrates the ITRs and intervening DNA into the genome at TTAA sites. The Super PiggyBac Transposase is delivered to the cell via the Super PiggyBac Transposase Expression Vector, which is co-transfected with one or more PiggyBac Vectors.

Footprint-free removal that leaves no PiggyBac sequences behind—In addition to ease-of-use, consistency, and the lack of limits on DNA insert size, what sets this system apart is the ability to reverse the integration reaction in a footprint-free way—with the Excision Only PiggyBac Transposase (Cat.# PB220PA-1), the ITRs and cargo that the Super PiggyBac Transposase integrates into the genome can be removed, leaving behind the original genomic sequence and nothing else.

  • Make transgenic cell lines with a single transfection
  • Integrate multiple PiggyBac Vectors in a single transfection
  • Insert an expression cassette into human, mouse, and rat cells
  • Deliver virtually any-sized DNA insert, from 10 – 100 kb
  • Choose from PiggyBac Vectors that express your gene-of-interest from constitutive or inducible promoters and include a variety of markers
  • Determine the number of integration events with the PiggyBac qPCR Copy Number Kit (Cat.# PBC100A-1)

Customer Agreements
Academic customers can purchase PiggyBac Transposon System components for internal research purposes for indefinite use, whereas commercial customers must sign a customer agreement for a six-month, limited-use license to test the technology.For

For end user license information, see the following:

* SBI is fully licensed to distribute PiggyBac vectors as a partnership with Transposagen Biopharmaceuticals, Inc.

How It Works

The PiggyBac Transposon System’s Cut-and-Paste Mechanism

The efficient PiggyBac Transposon System uses a cut-and-paste mechanism to transfer DNA from the PiggyBac Vector into the genome. If only temporary genomic integration is desired, the Excision-only PiggyBac Transposase can be transiently expressed for footprint-free removal of the insert, resulting in reconstitution of the original genome sequence.

The PiggyBac Transposon System’s cut-and-paste mechanism

Figure 1. The PiggyBac Transposon System’s cut-and-paste mechanism.

Step 1 The Super PiggyBac Transposase binds to specific inverted terminal repeats (ITRs) in the PiggyBac Cloning and Expression Vector and excises the ITRs and intervening DNA.

Step 2 The Super PiggyBac Transposase inserts the ITR-Expression Cassette-ITR segment into the genome at TTAA sites.

Step 3 The Excision-only Super PiggyBac Transposase can be used to remove the ITR-Expression Cassette-ITR segment from the genome, for footprint-free removal.

Supporting Data

One transfection can integrate one or more genes that can be precisely removed

Efficient transgenesis with the Super PiggyBac Transposase and both single- and dual-promoter PiggyBac Vectors


Figure 2. Efficient transgenesis with the Super PiggyBac Transposase and both single- and dual-promoter PiggyBac Vectors. (Top four panels) Co-transfection with the Super PiggyBac Transposase Expression Vector (Cat.# PB210PA-1) and a Dual Promoter PiggyBac Cloning and Expression Vector (Cat.# PB513B-1) into HeLa cells demonstrates the efficient integration delivered by SBI’s PiggyBac Transposon System. After ten days of puromycin selection, only the cells co-transfected with the Super PiggyBac Transposase (+PB, right two panels) show robust growth and GFP fluorescence. (Bottom four panels) Co-transfection with the Super PiggyBac Transposase Expression Vector (Cat.# PB210PA-1) and a Single Promoter PiggyBac Cloning and Expression Vector (Cat.# PB531A-2) into HEK293 cells further demonstrates the efficient integration delivered by SBI’s PiggyBac Transposon System. After seven days of growth, the majority of cells that received the Super PiggyBac Transposase Expression Vector (+PB, right two panels) were RFP positive.

Simultaneous integration of multiple PiggyBac Vectors is also highly efficient


Figure 3. Simultaneous integration of multiple PiggyBac Vectors is also highly efficient. METHODS: Three different PiggyBac transposon vectors (Cat.# PB513B-1, Cat.# PB533A-2, and Cat.# PB531A-2) were co-transfected with (left panels) or without (right panels) the Super PiggyBac Transposase Expression Vector (Cat.# PB210PA-1) into Human HT1080 cells. Puromycin and neomycin selection was applied for seven days. The cells that were co-transfected with the Super PiggyBac Transposase Expression Vector were puro and neo resistant, GFP-positive, and RFP-positive. Background GFP-positive cells that are puro resistant stem from random PB513B-1 integrations during the puromycin selection. The non-PiggyBac-mediated integration rate in those cells was extremely low and no RFP-positive cells were identified.


  • Møller, HD, et al. (2018) CRISPR-C: circularization of genes and chromosome by CRISPR in human cells. Nucleic Acids Res.. 2018 Dec 14; 46(22):e131. PM ID: 30551175
  • Shinmura, K, et al. (2018) Defective repair capacity of variant proteins of the DNA glycosylase NTHL1 for 5-hydroxyuracil, an oxidation product of cytosine. Free Radic. Biol. Med.. 2018 Dec 12; 131:264-273. PM ID: 30552997
  • Fujii, M, et al. (2018) Human Intestinal Organoids Maintain Self-Renewal Capacity and Cellular Diversity in Niche-Inspired Culture Condition. Cell Stem Cell. 2018 Dec 6; 23(6):787-793.e6. PM ID: 30526881
  • Lee, JH, et al. (2018) Forkhead Box O3 promotes cell proliferation and inhibits myotube differentiation in chicken myoblast cells. Br. Poult. Sci.. 2018 Nov 14;. PM ID: 30427204
  • Andres, SF, et al. (2018) IMP1 3′ UTR shortening enhances metastatic burden in colorectal cancer. Carcinogenesis. 2018 Nov 8;. PM ID: 30407516
  • Schertzer, M, et al. (2018) A piggyBac-based toolkit for inducible genome editing in mammalian cells. bioRxiv. 2018 Oct 20;. Link: bioRxiv
  • Han, Y, et al. (2018) Superiority of SpiroZin2 Versus FluoZin-3 for monitoring vesicular Zn2+ allows tracking of lysosomal Zn2+ pools. Sci Rep. 2018 Oct 9; 8(1):15034. PM ID: 30302024
  • Rodriguez-Rodriguez, J, et al. (2018) Distinct Roles of RZZ and Bub1-KNL1 in Mitotic Checkpoint Signaling and Kinetochore Expansion. Current Biology. 2018 Oct 1;. Link: Current Biology
  • Hunter, M, et al. (2018) Optimization of Protein Expression in Mammalian Cells. Curr Protoc Protein Sci. 2018 Sep 28;:e77. PM ID: 30265450
  • Kim, TH & Zhou, H. (2018) Overexpression of Chicken IRF7 Increased Viral Replication and Programmed Cell Death to the Avian Influenza Virus Infection Through TGF-Beta/FoxO Signaling Axis in DF-1. Front Genet. 2018 Sep 25; 9:415. PM ID: 30356848
  • Wang, Y, et al. (2018) The cerebral cavernous malformation disease causing gene KRIT1 participates in intestinal epithelial barrier maintenance and regulation. FASEB J.. 2018 Sep 25;:fj201800343R. PM ID: 30252535
  • Brasino, M, et al. (2018) Anti-EGFR Affibodies with Site-Specific Photo-Cross-Linker Incorporation Show Both Directed Target-Specific Photoconjugation and Increased Retention in Tumors. J. Am. Chem. Soc.. 2018 Sep 19; 140(37):11820-11828. PM ID: 30203972
  • Kirk, JM, et al. (2018) Functional classification of long non-coding RNAs by k-mer content. Nat. Genet.. 2018 Sep 17;. PM ID: 30224646
  • Klein, CH, et al. (2018) PDEδ inhibition impedes the proliferation and survival of human colorectal cancer cell lines harboring oncogenic KRas. Int. J. Cancer. 2018 Sep 8;. PM ID: 30194764
  • Wei, Z, et al. (2018) Fam198a, a member of secreted kinase, secrets through caveolae biogenesis pathway. Acta Biochim. Biophys. Sin. (Shanghai). 2018 Sep 5;. PM ID: 30188967
  • Strubberg, AM, et al. (2018) The Zinc Finger Transcription Factor PLAGL2 Enhances Stem Cell Fate and Activates Expression of ASCL2 in Intestinal Epithelial Cells. Stem Cell Reports. 2018 Aug 14; 11(2):410-424. PM ID: 30017821
  • Gombodorj, N, et al. (2018) Correlation between high FBXW7 expression in pretreatment biopsy specimens and good response to chemoradiation therapy in patients with locally advanced esophageal cancer: A retrospective study. J Surg Oncol. 2018 Aug 11;. PM ID: 30098297
  • Nanki, K, et al. (2018) Divergent Routes toward Wnt and R-spondin Niche Independency during Human Gastric Carcinogenesis. Cell. 2018 Aug 9; 174(4):856-869.e17. PM ID: 30096312
  • Fuentes, DR, Swigut, T & Wysocka, J. (2018) Systematic perturbation of retroviral LTRs reveals widespread long-range effects on human gene regulation. Elife. 2018 Aug 2; 7. PM ID: 30070637
  • Mossine, VV, et al. (2018) Interaction of Bacterial Phenazines with Colistimethate in Bronchial Epithelial Cells. Antimicrob. Agents Chemother.. 2018 Aug 1; 62(8). PM ID: 29784845